Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing



Rating:

Share or cite this content

Citations should be made in the following way:
C. Turnbull (Oxford (Oxfordshire), United Kingdom), R. Heitmar (Birmingham, United Kingdom), J. Stradling (Oxford (Oxfordshire), United Kingdom). The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial. 4385

Member's Comments

No comment yet.

Related content which might interest you: The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial. Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018 Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020 Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019 Year: 2020 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 52 (4) 1801177; 10.1183/13993003.01177-2018 Year: 2018 Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials. Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018 Year: 2018 The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019 A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea Source: Eur Respir J 2010; 35: 138-145 Year: 2010 Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study Source: Eur Respir J 2014; 44: 140-149 Year: 2014